HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community.

Abstract
Chronic kidney disease (CKD) is a major health problem because of its high prevalence, associated complications and high treatment costs. Several aspects of CKD differ significantly in the Eastern European nephrology community compared with Western Europe because of different geographic, socio-economic, infrastructure, cultural and educational features. The two most frequent aetiologies of CKD, DM and hypertension, and many other predisposing factors, are more frequent in the Eastern region, resulting in more prevalent CKD Stages 3-5. Interventions may minimize the potential drawbacks of the high prevalence of CKD in Eastern Europe, which include several options at various stages of the disease, such as raising public, medical personnel and healthcare authorities awareness; early detection by screening high-risk populations; preventing progression and CKD-related complications by training health professionals and patients; promoting transplantation or home dialysis as the preferred modality; disseminating and implementing guidelines and guided therapy and encouraging/supporting country-specific observational research as well as international collaborative projects. Specific ways to significantly impact CKD-related problems in every region of Europe through education, science and networking are collaboration with non-nephrology European societies who have a common interest in CKD and its associated complications, representation through an advisory role within nephrology via national nephrology societies, contributing to the training of local nephrologists and stimulating patient-oriented research. The latter is mandatory to identify country-specific kidney disease-related priorities. Active involvement of patients in this research via collaboration with the European Kidney Patient Federation or national patient federations is imperative to ensure that projects reflect specific patient needs.
AuthorsMehmet Şükrü Sever, Kitty J Jager, Raymond Vanholder, Benedicte Stengel, Jerome Harambat, Patrik Finne, Vladimir Tesař, Myftar Barbullushi, Inga A Bumblytė, Elena Zakharova, Goce Spasovski, Halima Resic, Andrzej Wiecek, Peter J Blankestijn, Annette Bruchfeld, Mario Cozzolino, Dimitris Goumenos, Maria Jose Soler, Ivan Rychlík, Kate I Stevens, Christoph Wanner, Carmine Zoccali, Ziad A Massy
JournalClinical kidney journal (Clin Kidney J) Vol. 14 Issue 1 Pg. 23-35 (Jan 2021) ISSN: 2048-8505 [Print] England
PMID33570513 (Publication Type: Journal Article, Review, Comment)
Copyright© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: